Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients | Financial Post
Spectral Medical Inc. achieved a significant milestone by enrolling 90 patients in its TIGRIS trial, a step towards FDA approval for its sepsis treatment, PMX. This progress may trigger a milestone payment from Baxter, maintaining PMX's exclusive distribution rights. Spectral aims to introduce a new ICU care standard in the U.S.
Reference News
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients | Financial Post
Spectral Medical Inc. achieved a significant milestone by enrolling 90 patients in its TIGRIS trial, a step towards FDA approval for its sepsis treatment, PMX. This progress may trigger a milestone payment from Baxter, maintaining PMX's exclusive distribution rights. Spectral aims to introduce a new ICU care standard in the U.S.